Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, ...
uterine artery embolization and magnetic resonance guided focused ultrasound surgery. While there is a general consensus on the treatment of submucosal fibroids, the management of intramural ...
Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...
Theramex has announced that the Scottish Medicine Consortium (SMC) has recommended Yselty® for the treatment of moderate to severe symptoms of uterine fibroids (UFs) aligned to the product indication ...
Relugolix plus the two hormonal drugs are also approved in the US as Myfembree for uterine fibroids, where the GnRH antagonist is also sold on its own as Orgovyx for prostate cancer. Pfizer agreed ...
"I am pleased we have been able to recommend a further treatment option for managing moderate to severe symptoms of uterine fibroids," commented Jonathan Benger, NICE's chief medical officer and ...